Pharma funds still under the weather
Regulatory action and competition in the US market have hit revenues
The strong bull run in S&P BSE Healthcare that commenced in early 2012 came to an end in late 2015. Since then, the index has been trending down. Pharma funds, which are benchmarked against S&P BSE Healthcare and Nifty Pharma indices, have taken a knock too.
There are four funds in this sector, namely Reliance Pharma, SBI Pharma, Tata India Pharma & HealthCare and UTI Pharma & H...
Read the rest of this article by Signing up for Portfolio.
It's completely free!
SIGN UP NOW
Investment alerts,End of day market reports, Market news analysis,External research reports and Technical calls
Daily update on Business and Market news via email
'Your Market Corner' Widget with personalized business and market news